Home 2021

Archives

access to treatment, NOR-SWITCH

Biosimilars: Improve access to treatment & reduce cost

Tore K Kvien & Guro L Goll argue that biosimilars are an opportunity for improving access to treatment & reducing cost and provide comment on the NOR-SWITCH study.

Follow Us

Advertisements